CRCarol R. Reinero

Carol R. Reinero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carol R. Reinero has a total of 211 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Successful immunosuppressive treatment of hypersensitivity pneumonitis secondary to lycoperdonosis in a dog

    by Iliana Navarro, Aida Vientós-Plotts, Isabelle Masseau, Erin Farrell, Angela Royal, Carol R Reinero

    A 7-year-old neutered male Cocker Spaniel with unrestricted access to rural land presented for progressive lethargy, tachypnea, and cough. Thoracic radiographs showed an unstructured interstitial pattern. Fine-needle aspirate (FNA) lung cytology identified pyogranulomatous inflammation with intralesional mushroom spores. Acute hypersensitivity pneumonitis (HP) was suspected, and treatment was initiated with oxygen supplementation and an immunosuppressive dosage of corticosteroid. Thoracic computed tomography (CT) and bronchoalveolar lavage (BAL) were performed on day 6, month 2, and year 1 to track therapeutic response and assess architectural changes. Clinical signs guided prednisone tapering and discontinuation. One year later, thoracic CT and BAL confirmed re-exposure to mushroom spores with mild persistent inflammation and CT changes suggestive of mixed parenchymal and small airway disease despite absent clinical signs. This case report emphasizes the importance of rapid identification of pulmonary mushroom spores for prompt immunosuppressive treatment. Unlike prior reports of lycoperdonosis with acute, fulminating, and generally fatal outcomes, this dog developed chronic HP.

  • Open Access

    EXPRESS: Developmental lung disease with associated pulmonary hypertension in a Sphynx kitten

    by Elizabeth Martin, Kelly Wiggen, Kurt Williams, Isabelle Masseau, Carol Reinero

    Case Summary: This case report describes the clinical presentation, diagnostic findings, and clinicopathologic features consistent with developmental lung disease (DLD) and pulmonary hypertension (PH) in a 3-month-old, Sphynx munchkin kitten. The kitten was originally referred for episodes of respiratory distress unresponsive to medical management consisting of diuretics, antibiotics, and corticosteroids. Echocardiography was consistent with a high probability of PH of a non-cardiac etiology. Baseline blood work, thoracic radiographs, thoracic CT with triphasic angiography, and a bronchoalveolar lavage were performed. Thoracic CT revealed diffuse ground-glass opacity with bronchiolectasis and distention of the pulmonary artery and branches. The bronchoalveolar lavage identified an equal distribution of non-degenerative neutrophils and macrophages with erythrophagocytosis and no overt neoplastic cells or infectious organisms appreciated. The kitten was humanely euthanized due to lack of an identifiable treatable etiology and poor prognosis. Histopathological findings were most consistent with DLD with diffuse acinar underdevelopment and vascular changes including pulmonary capillary hemangiomatosis, findings not previously reported in the feline DLD literature. Relevance and novel information: There is a paucity of literature describing DLD and its potential to cause PH in cats. A comprehensive diagnostic evaluation ultimately including histologic examination is needed to reach a diagnosis of DLD. In the presence of PH in a young kitten without any identifiable primary cardiac or respiratory cause, pulmonary thromboembolism, or cardiac parasites, a DLD should be considered.

  • Open Access

    Diagnostic limitations of oropharyngeal swab cultures and inconsistent presence of secondary bacterial infection in canine aspiration pneumonia

    by Aida Vientós-Plotts, Ashley Reinero, Tamara Gull, Carol Reinero

    Objective: In dogs with aspiration pneumonia (AP), our objectives were to determine whether oropharyngeal (OP) swab isolates would match bronchoalveolar lavage fluid (BALF) isolates and determine the frequency of secondary bacterial infection (SBI) in AP by use of 4 definitions. Methods: 30 client-owned dogs with clinical diagnosis of AP (cough or fever, and radiographic alveolar pattern with historical vomiting or regurgitation) with OP and BALF cultures were prospectively enrolled from 2019 to 2023. Exclusion criteria included antimicrobial administration within 14 days of presentation or inability to undergo BALF collection. Definitions of SBI included (1) positive BALF culture (noncontaminant), (2) veterinary criteria (septic inflammation in BALF or nonseptic inflammation with positive culture having ≥ 1.7 × 10 3 CFU/mL), (3) human criteria (> 7% of cells with intracellular bacteria or positive culture with ≥ 10 4 CFU/mL), and (4) clinical recovery without antimicrobials. Results: All OP and 16 of 30 BALF cultures were positive, yielding a median of 4 organisms (range, 1 to 6 organisms) and 1 organism (range, 0 to 3 organisms), respectively, with significantly more positive OP isolates. Most OP isolates (91%) were not recovered from BALF. Absence of SBI was documented in 30% to 77% of dogs with AP, depending on definition. Conclusions: OP swabs were polymicrobial, with most organisms (91%) not present in BALF. Many dogs with AP did not meet 1 or more definitions of SBI. Clinical Relevance: Using OP cultures as surrogates for BALF cultures was inappropriate for dogs with AP. Not all dogs with AP had SBI, necessitating further study of when antimicrobial therapy could be avoided versus when it is warranted.

  • Open Access

    Comparison of sedated respiratory-gated computed tomography to anesthetized inspiratory-expiratory breath-hold computed tomography in dogs with respiratory disease

    by Iliana Navarro, Aida Vientós-Plotts, Isabelle Masseau, Alok Dwivedi, Carol Reinero

    Objective: To determine the diagnostic accuracy of sedated respiratory-gated (RG) CT as a minimally invasive surrogate for anesthetized, ventilator-assisted inspiratory-expiratory breath-hold (I:E-BH) CT scans by being able to identify CT lung patterns and subpatterns, abnormal and normal lung attenuation scores, and bronchomalacia (BM) in dogs with respiratory disease. Methods: Sedated RG CT and anesthetized I:E-BH CT images were sequentially acquired in 50 client-owned dogs with respiratory clinical signs. Computed tomography lung patterns and subpatterns, 2 CT severity scores, and the presence of BM were assessed. Agreement was estimated using unweighted and weighted Cohen κ coefficients and Bland-Altman plots. McNemar tests and mixed-effects logistic or ordinal logistic regressions were utilized to evaluate discordant pairs between CT techniques. Results: Both scan types had minimal motion artifact. Nodular pattern and airspace nodules and reticular and subpleural interstitial thickening subpatterns were significantly underestimated in RG CT compared to I:E-BH CT. A fair agreement was estimated between the 2 methods for normal lung scores but not for abnormal lung scores, and for BM. There was a significant difference between the two techniques in diagnosing clinical BM. Inspiratory-expiratory breath-hold CT yielded more BM diagnoses, especially in younger dogs with milder BM scores. Conclusions: In dogs with respiratory disease, RG CT had good concordance with I:E-BH CT on most major lung patterns but not some nodular and linear subpatterns, underdetecting subtle but clinically relevant lesions. The probability of diagnosing clinical BM is higher with I:E-BH CT, particularly in milder cases. Clinical Relevance: Compared to RG CT, anesthetized I:E-BH CT provides superior technique and detail that allows for characterization of some subpatterns, which could have diagnostic implications.


  • A multidisciplinary diagnostic approach to pulmonary fibrosis in dogs and cats

    by Carol R. Reinero, Isabelle Masseau, Kurt J. Williams

    Idiopathic pulmonary fibrosis (IPF) describes a severe, progressive, and ultimately fatal end-stage lung disorder in dogs and cats. The term IPF was coined in dogs and cats for 2 reasons: 1) the cause of the fibrosis at the time of diagnosis was unknown (i.e., presumed idiopathic); and 2) the condition was believed to resemble human IPF, the most common type of progressive fibrotic lung disease in people. However, pulmonary fibrosis in dogs and cats is not a single homogeneous disorder, does not consistently resemble all histologic features of human IPF, and is rarely exhaustively evaluated for an underlying cause. Fibrosis is a response to injury, and knowledge of the type of injury has critical implications for disease management, especially if identified before end-stage lesions occur. We offer an approach to a thorough diagnostic evaluation, including clinical, imaging, laboratory, and pathology data, which sets the stage for multidisciplinary discussions. Given that thoracic computed tomography (CT) is increasingly utilized to identify features compatible with pulmonary fibrosis in dogs and cats, we describe these CT patterns and their pitfalls. Diagnostic respiratory evaluations should investigate possible inciting causes, provide information about disease extent and severity, and identify comorbid disorders. Such evaluations will allow optimized therapy, including avoiding treatments that may have adverse effects or be overtly harmful. Importantly, although end-stage fibrotic lungs currently have no viable treatment, early recognition of known triggers of fibrosis could ultimately enable novel targeted therapy while there is still time to alter the clinical course.


  • Microbiota Analysis and Standard Culture Identify Bacteria in Ophthalmic Trypan Blue Solution Commonly Used During Canine Cataract Surgery

    by Aaron C. Sieve, Elizabeth A. Giuliano, Zachary L. McAdams, Aida Vientós‐Plotts, Carol R. Reinero, Aaron C. Ericsson

    Objective: To identify bacterial communities and quantify endotoxin within different lot numbers and brands of commercially available sterile ophthalmic trypan blue solution commonly used during canine cataract surgery; with the ultimate goal of improving our understanding of possible factors associated with post‐operative fibrin web (FW) formation. Procedures: Five samples from two production lots of three different brands of trypan blue (30 samples total) and reagent controls were collected for deoxyribonucleic acid (DNA) extraction, 16S ribosomal ribonucleic acid (rRNA) sequencing, sequence analysis, and classification. All samples underwent conventional aerobic and capnophilic bacterial culture. Assays for endotoxin quantification included fluorogenic, kinetic chromogenic, and turbidimetric methods. Statistical analysis assessed DNA concentration, microbial richness, and alpha (α) and beta (β) diversity. Results: an‐blue (4/10), VisionBlue (3/10), and MONOBLUE Saf‐R (3/10) all cultured at least one organism in each lot number from the enrichment broth. Genera cultured included Staphylococcus spp., Lysinibacillus spp., Bacillus spp., and Micrococcus spp. Analysis of sequencing data revealed no significant difference in α‐diversity but significant differences in weighted and unweighted measures of β‐diversity (Bray–Curtis and Jaccard distances) between an‐blue and VisionBlue samples. Differential abundance testing found Halomonas and Saccharofermentans to be genus‐level biomarkers. Dominant families recovered from sequencing included Bifidobacteriaceae, Christensenellaceae, Clostridiaceae, Erysipelotrichaceae, Lachnospiraceae, Lactobacillaceae, Oscillospiraceae, Propionibacteriaceae, WCHB1‐41, and Streptococcaceae. Endotoxin quantification could not be performed at clinically relevant dilutions. Conclusions: Significant brand‐specific differences in relative abundance of shared bacterial taxa were noted between an‐blue and VisionBlue. Halomonas and Saccharofermentans were identified as genus‐level biomarkers.

  • Open Access

    Lower esophageal sphincter achalasia-like syndrome causing megaesophagus in a cat

    by Carol Reinero, Megan Grobman, Aida Vientós-Plotts, Isabelle Masseau, Charlotte Gerhard

    Case summary: Feline megaesophagus (ME) is a rare failure of esophageal motility leading to regurgitation, weight loss and sometimes death in cats. It has been identified secondarily to neurologic and neuromuscular disorders, mechanical obstruction of the esophagus (eg, vascular ring anomalies, esophageal stricture) and upper airway obstruction among others; when no cause is found, it is considered idiopathic. Videofluoroscopic swallow studies (VFSSs), especially using an unrestrained free-feeding protocol, are underutilized for comprehensive evaluation of cats with regurgitation, including identifying the etiology of ME. In this case report, a 3-month-old male intact domestic shorthair cat with a history of regurgitation since weaning and radiographic evidence of ME had VFSS features compatible with a functional obstruction of the lower esophageal sphincter (LES) consistent with LES achalasia-like syndrome. Medical management with sildenafil failed to improve clinical signs, and surgical correction of LES achalasia using a Heller myotomy and Dor fundoplication was declined. As a result of caregiver compassion fatigue from persistent regurgitation, euthanasia was elected. Relevance and novel information: Videofluoroscopic documentation of functional obstruction of the LES (ie, LES achalasia-like syndrome) can identify a novel etiology of feline ME. Free-feeding unrestrained VFSS protocols are recommended to allow physiologic assessment of swallowing disorders with no higher risk of aspiration than eating and drinking at home. Recognition of LES achalasia-like syndrome may lead to further study of directed treatments targeting the functional obstruction as has been carried out in humans and dogs.


  • Open Access

    Objective assessment of computed tomographic pulmonary attenuation of inspiratory and expiratory series in dogs with and without bronchomalacia

    by Charlotte Gerhard, Isabelle Masseau, Aida Vientos-Plotts, Gregory F. Petroski, Carol Reinero

    OBJECTIVE: To document objective metrics of attenuation of the pulmonary parenchyma on inspiratory and expiratory breath-hold CT in dogs with bronchomalacia (BM) and dogs without BM (NoBM) using automated software analysis. Metrics included mean lung attenuation, percent low-attenuation area at −856 HU, percent high-attenuation area at −700 HU, and percent attenuation area between −600 and −250 HU. ANIMALS: Client-owned dogs with BM (n = 123) and NoBM (20). METHODS: This retrospective study utilized 3D Slicer software (Brigham and Women's Hospital) to assess pulmonary CT attenuation. Analysis used Spearman correlation and 2-way ANOVA with beta regression. RESULTS: Comparing the difference between inspiratory and expiratory phases, there was a significantly greater increase in mean lung attenuation (P = .001), a significant reduction in percent low-attenuation area at −856 HU (P = .016), and a significant increase in percent high-attenuation area at −700 HU and percent attenuation area between −600 and −250 HU (P < .001 and P < .0001, respectively) in BM versus NoBM dogs. CONCLUSIONS: The higher inspiratory and expiratory difference in lung attenuation in BM compared to NoBM dogs supports the presence of impaired parenchymal aeration downstream of segmental and subsegmental airway collapse. CLINICAL RELEVANCE: Quantitative image analysis holds promise for objectively evaluating changes with BM.


  • Open Access

    Multistrain probiotics fail to modulate the asthmatic phenotype, respiratory microbiota, and immune responses in cats

    by Julia D. Remaks, Aida I. Vientos-Plotts, Hansjorg Rindt, Zachary McAdams, Aaron C. Ericsson, Carol R. Reinero

    OBJECTIVE: To determine if multistrain probiotics administered to asthmatic cats treated with anti-inflammatory glucocorticoids would attenuate the asthmatic phenotype and beneficially alter respiratory, blood, and oropharyngeal (OP) microbial communities and immune parameters versus placebo. ANIMALS: 13 client-owned asthmatic cats. METHODS: A randomized, blinded, placebo-controlled clinical trial of asthmatic cats receiving anti-inflammatory glucocorticoids with oral multistrain probiotics or placebo assessed owner-perceived improvement and airway eosinophilia at baseline and after 2 weeks of treatment. Bronchoalveolar lavage fluid (BALF), blood, OP, and rectal microbial communities were compared using 16S rRNA amplicon sequencing. Real-time PCR for transcription factors, activation markers and cytokines, and IgA ELISAs were evaluated. Statistical analyses used 2-way repeated-measures ANOVA or permutational ANOVA (significance, P < .05). RESULTS: After treatment, there were no significant differences in owner-perceived clinical signs or mean ± SEM BALF eosinophils between groups. There was a significant decrease in rectal α-diversity but not in α- or β-diversity in BALF, blood, or OP between groups or over time. There were no significant differences in CD25, FoxP3, GATA, Helios, IL-4, IL-5, IL-10, IL-13, IL-17, IFN-γ mRNA, or serum or BALF IgA between groups or over time. CLINICAL RELEVANCE: In asthmatic cats, oral multistrain probiotics failed to improve owner-perceived signs, reduce airway eosinophilia, modify microbial community composition, or alter assessed immune responses versus placebo or over time. Longer treatment, different probiotic composition or delivery (eg, aerosolized), or larger number of cats would represent the next stages of study.